NutraLife BioSciences, Inc. (NLBS)

NutraLife BioSciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Net Income	0	-7.68	-2.9	-4.07	-2.07	-23.63	-1.53	-2.1	-2.08	-2.08	Upgrade
Depreciation & Amortization	0	0.33	0.39	0.23	0.07	0.08	0.06	0.06	0.05	0.05	Upgrade
Share-Based Compensation	0	2.57	0.5	0.61	0	19.02	0.57	0.62	0.08	1.28	Upgrade
Other Operating Activities	-	4.3	0.72	0.3	1.77	3.51	0.23	0.58	0.71	-0.14	Upgrade
Operating Cash Flow	0	-0.49	-1.28	-2.93	-0.23	-1.02	-0.67	-0.85	-1.23	-0.9	Upgrade
Capital Expenditures	0	0	0	-1.59	-0.58	-0.17	-0.02	-0.04	-0.03	-0.24	Upgrade
Other Investing Activities	-	-0.68	-	-	-0.04	-	-	-	-	-	Upgrade
Investing Cash Flow	0	-0.68	0	-1.59	-0.62	-0.17	-0.02	-0.04	-0.03	-0.24	Upgrade
Common Stock Issued	0	0.35	0.13	2.78	0.62	1.32	0.54	0.22	0.68	0.62	Upgrade
Other Financing Activities	-	0.95	1.15	1.34	0.48	0.03	0.15	0.67	0.54	0.45	Upgrade
Financing Cash Flow	0	1.3	1.27	4.12	1.1	1.35	0.68	0.89	1.22	1.06	Upgrade
Net Cash Flow	0	0.14	-0.01	-0.41	0.25	0.16	-0	-0	-0.04	-0.08	Upgrade
Free Cash Flow	0	-0.49	-1.28	-4.53	-0.82	-1.19	-0.69	-0.9	-1.26	-1.14	Upgrade
Free Cash Flow Margin	-	-77.78%	-102.27%	-212.26%	-21.99%	-66.43%	-175.44%	-461.66%	-2020.43%	-190.96%	Upgrade
Free Cash Flow Per Share	-	-0.00	-0.01	-0.04	-0.01	-0.02	-0.02	-0.04	-0.06	-0.06	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.